Update - July 27. SHAREHOLDERS UPDATES: OK, so

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
471
Update - July 27.

SHAREHOLDERS UPDATES:

OK, so sometimes some of you do not understand nor believe some of my assumptions and how I come about my decisions. This morning, I am able to once again, use examples of my current companies in my portfolio to show how "some" assumptions "CAN and DO" translate to benefit other companies and their performance. Many of you, once again, will brush my statements as a "scheme" or a P&D maneuver. So, this is more or less addressed for those who are intelligent enough to understand things, and appreciate the fact that I share my ideas and assumptions "openly" with the shareholders, knowingly, that the "bashers" and "nay-sayers" will not understand nor believe and will only use my information to fuel their hate and stoke their ignorant fire.

So, here is what I posted earlier: (P.S. Always use your own research and DD).

SHAREHOLDERS UPDATES:

We were celebrating our latest "small victory" here in Dallas. What I'm referring to, is the fact that this morning OTC Markets up listed our UITA company to a "fully reported SEC filer". Now, some of you may not be able to "connect the dots", so let me explain.

No two companies are the same, and therefore have different set of challenges and circumstances. However, I look for some common denominators so that I can base my assessments and attempt to predict behavior and sometimes even possible outcome for each of these companies. That is why, from time to time, I use examples so as to share with you our shareholders, my rationale of how I arrive at some of these assumptions and therefore base my decisions. I attempt to be transparent and honest, but its not always understood or taken by some of the shareholders in the spirit and intent that I'm trying to convey. So, by seeing , for example, how our Consultia Group of Accountants were helpful with UITA this morning, I feel positive with confidence that they will do same for AURI,BDGR, SUTI, PRPM, TSRR and PBHG. So, to parallel the two achievements, here is what I shared with our UITA shareholders base this morning. I hope you see where we are going, and understand why I made several references "in the past" with our TICKERS achieving certain basic criteria for trading on "upper tiers".

I posted on UITA:

SHAREHOLDERS UPDATES:

So, the company moved on to "current status" on OTC Markets this morning!

This is not only "great news" for our shareholders, but also a great confirmation for us "the management". The confirmation that I'm talking about has to do with our choice of hiring Consultia, who are incredibly thorough and are very professional. Their help with UITA becoming "fully reporting filer" and moving up to the OTCPK "current status" was another vote of confidence and another confirmation that "we" made a good decision hiring them to do the same for all of our OTCPK companies.

Financial Reporting/Disclosure UITA:

OTC Marketplace Pink Current

Reporting Standard U.S. Reporting: SEC Reporting

CIK 0001334740

Fiscal Year End 12/31

Audited Status Audited

So, we have them start at AURI now, and what we want to see is this on all our corporate profiles.

Also, notice that we are just a little above a penny, and still "made it in".

That's what I was trying to explain on my other companies as far as "certain trading criteria" that had to be met. And yet, sometimes things can "slide" and we get in!

https://www.facebook.com/MJVentureCapital/

ProTek Capital Inc. (PRPM) Stock Research Links

PRPM Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 0

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 2

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 0

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 3

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading

Top 5 Most Recently Viewed Articles

Conformal Coatings Market Set for Significant Growth by 2032

Updated Category News Views 233

The conformal coatings market surged ahead with projections showing it could reach USD 1.7 billion by 2032. This translates into a compound annual growth rate (CAGR) of 5.7% from 2024 to 2032, driven primarily by advancements in electronic protection technologies. Traders had better keep their eyes peeled—this ain't just a bump; it's a substantial shift. What’s...

Continue Reading
Japanese Mobile Battery Industry Forecasts Significant Growth

Updated Category News Views 122

Japan Mobile Battery Market Overview The mobile battery market in Japan is witnessing significant growth, with a valuation of JPY 207.96 billion in 2024 and projected to escalate to JPY 358.97 billion by 2033, marking a compound annual growth rate (CAGR) of 6.48% from 2025 to 2033. This growth trajectory highlights not only increasing consumer demands but also rapidly...

Continue Reading
Givastomig: A Promising Player in Gastric Cancer Therapy

Updated Category News Views 74

Givastomig's Advances in Gastric Cancer Research I-Mab (NASDAQ: IMAB), a biotech firm focused on developing cancer immunotherapies, recently presented exciting results from its Phase 1 clinical trial involving givastomig. This innovative bispecific antibody immunostimulant was unveiled at a prominent medical conference, demonstrating its effectiveness in treating advanced...

Continue Reading
Rani Therapeutics Partners with Chugai for Drug Delivery Breakthrough

Updated Category News Views 245

Rani Therapeutics Engages with Chugai Pharmaceutical Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) recently announced a significant collaborative effort with Chugai Pharmaceutical Co., Ltd., resulting in an enthusiastic response from investors. This collaboration aims to utilize Rani's innovative RaniPill oral drug delivery system alongside Chugai's experimental...

Continue Reading
Revizto's Brand Revamp: A Bold Step Towards Future Growth

Updated Category News Views 142

Revizto Introduces a Fresh Brand Identity As project complexities continue to rise in the construction industry, Revizto is making important modifications to its public image. The renowned collaboration platform, specifically designed for the Architecture, Engineering, Construction, and Operations (AECO) sectors, recently unveiled its refreshed brand identity,...

Continue Reading